TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Mylan gets FDA approval of blood pressure drug

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Daily Photo Galleries

Tuesday, Nov. 13, 2012, 10:34 a.m.
 

Mylan Inc. said on Tuesday that it gained Food and Drug Administration approval for a generic blood pressure drug.

Cecil-based Mylan said it has started shipping Sildenafil Citrate tablets, the generic version of Pfizer Inc.'s Revatio.

Revatio had U.S. sales of $338.7 million in the 12 months ended Sept. 30.

Alex Nixon is a staff writer for Trib Total Media. He can be reached at 412-320-7928 or anixon@tribweb.com.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Stories

  1. Gorman: DiNucci perfect fit for Pine-Richland
  2. Steelers defense takes aim at Ravens QB Flacco
  3. High school football roundup: No. 13 Riverside upsets Beth-Center in 1st round
  4. Penguins GM Rutherford: Malkin’s play belies fact he missed training camp
  5. Attorney General Kane injured in auto accident
  6. Evaporating cap on Pa. gasoline taxes to offset drops at pump
  7. Steelers notebook: Ravens enter short-handed at tight end
  8. FCC chairman floats ‘hybrid’ ruling on net neutrality
  9. 5 Cal U football players arrested for assault; Saturday’s game canceled
  10. Young leads Pitt’s new-look lineup past IUP in exhibition opener
  11. Health insurers’ move towardd ‘high-value’ care providers may reduce choice
Subscribe today! Click here for our subscription offers.